Q2 Earnings 2024: With majors like Tata Consultancy Services (TCS), HCL Technologies, Infosys, Wipro, Tech Mahindra, Reliance Industries, Mahindra and Mahindra, Bharti Airtel, HUL, ITC, Marico, Dabur India, Adani Wilmar, Nestle India, L&T, Adani Enterprises, Apollo Hospitals, Mankind Pharma, Dr Reddy’s Laboratories, GAIL, LIC, SBI, Punjab National Bank, Axis Bank, HDFC Bank, IRCTC, Coal India, JK Lakshmi Cement, Havells India, Paytm, ABFRL, Zomato, PVR Inox, Lupin, Tata Motors, among many others having already released their Q2 earnings report, the earnings season is in full swing. Now, market participants and investors are keenly waiting for many others to announce their earnings report.
Today, companies like Oil and Natural Gas Corporation, Hindalco Industries, Britannia Industries, Shree Cements, NMDC, Bank Of India, Jubilant Foodworks, Godfrey Phillips India, Hindustan Copper, The Ramco Cements, Devyani International, Triveni Turbine, Blue Dart Express, PG Electroplast, BEML, Zydus Wellness, Balrampur Chini Mills, Keystone Realtors, Power Mech Projects, Orchid Pharma, Electronics Mart India, Dollar Industries, Bajaj Consumer Care, Parle Industries, among others are lined up to release their Q2 earnings report.
Till date, the corporate earnings scorecard for Q2FY25 has been weak but excluding commodities, it’s broadly in-line. According to a report by Motilal Oswal Financial Services (MOFSL), “The earnings spread has deteriorated, with only 62 per cent of MOFSL Coverage Universe either meeting or exceeding profit expectations. Consumption has emerged as a weak spot while select segments of BFSI are seeing asset-quality stress.”
Weak numbers from India Inc for the quarter have led to the biggest downgrades in earnings estimates since early 2020, according to Jefferies. The brokerage firm said it has downgraded earnings estimates for 63 per cent of the 121 companies under its coverage that have reported their latest quarterly results.
An analysis report by ICICI Securities said, “Lupin’s outperformance in Q2FY25 was driven by the launch of Mirabegron (50mg) in the US and momentum across India and EMEA. Complex product revenue in the US was up 0.8% YoY (10.8% QoQ) while volume dip in Suprep and doxycycline impacted growth in residual portfolio. Indian branded growth was ~11% and its OTC, tender and diagnostics biz further aided 8% growth in India biz. EBITDA grew 48.1% led by gSpiriva, mirabegron and higher PLI incentives. Near-term pipeline is healthy, including products like glucagon (USD 200 mn sales p.a.), Dalbavancin and Tolvaptan (Q1FY26 launch). Management maintains double-digit growth in the US in FY25.”
Today, majors including Oil and Natural Gas Corporation, Hindalco Industries, Britannia Industries, Shree Cements, NMDC, Bank Of India, Jubilant Foodworks, Godfrey Phillips India, Hindustan Copper, The Ramco Cements, Devyani International, Triveni Turbine, Blue Dart Express, PG Electroplast, BEML, Zydus Wellness, Balrampur Chini Mills, Power Mech Projects, Orchid Pharma, Electronics Mart India, Dollar Industries, Bajaj Consumer Care, Parle Industries, among others are lined up to release their Q2 results.
With major companies across sectors including TCS, HCL Technologies, Infosys, Wipro, Tech Mahindra, Reliance Industries, Mahindra and Mahindra, Bharti Airtel, HUL, ITC, Marico, Dabur India, Adani Wilmar, Nestle India, L&T, Adani Enterprises, Apollo Hospitals, Mankind Pharma, Dr Reddy’s Laboratories, GAIL, LIC, SBI, Punjab National Bank, Axis Bank, HDFC Bank, IRCTC, Coal India, JK Lakshmi Cement, Havells India, Paytm, ABFRL, Zomato, PVR Inox, Lupin, Tata Motors, and others already having released their Q2 numbers, the second quarter earnings season has picked up pace and is now in full swing.
Good Morning! The quarter earnings season has picked up pace now and we, at FinancialExpress.com, are continuously bringing to you all the updates on performance of India Inc across sectors. Going ahead as well, we will continue to keep you updated on these numbers, dividends announced by firms, reasons leading to their growth and even factors affecting the businesses. Stay tuned.